tbc-11251 has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, M | 1 |
| Coyne, T; Dhaun, N; Goddard, J; Kramer, W; Melville, V; Stavros, F; Swan, S; Webb, DJ | 1 |
1 review(s) available for tbc-11251 and Kidney Diseases
| Article | Year |
|---|---|
Endothelin antagonism and reversal of proteinuric renal disease in humans.
Topics: Endothelins; Humans; Isoxazoles; Kidney Diseases; Phenylpropionates; Proteinuria; Pyridines; Pyrimidines; Receptor, Endothelin A; Thiophenes | 2011 |
1 other study(ies) available for tbc-11251 and Kidney Diseases
| Article | Year |
|---|---|
The pharmacokinetic profile of sitaxsentan, a selective endothelin receptor antagonist, in varying degrees of renal impairment.
Topics: Adolescent; Adult; Aged; Endothelin A Receptor Antagonists; Female; Humans; Isoxazoles; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Receptor, Endothelin A; Thiophenes | 2007 |